Wegovy® tablets and diarrhea

How often diarrhea showed up on the tablet

All tablet-specific figures come from OASIS 4, called Study 7 in the US label: 204 adults without type 2 diabetes on the 25 mg tablet and 102 on placebo, followed for up to 64 weeks of treatment plus a seven-week check after stopping. ^[1] The EU product information quotes the trial’s diarrhea rate and classes diarrhea as very common, at least 1 person in 10; its frequency classes otherwise come from the injection studies, and it says OASIS 4 showed similar frequencies. ^[2] The sponsor’s registry record gives the underlying counts but is not peer reviewed. ^[3]

Why the tablet number looks lower

At first glance the tablet seems to cause less diarrhea than the pen: 17.6% against 30%. Look at the placebo column, though. People taking dummy tablets in OASIS 4 reported diarrhea about half as often as people on dummy injections in the trials behind Table 3 (8.8% against 16%). ^[1][2] Trials differ in who they enrol, how they ask about symptoms and how long they last, and the placebo rate captures much of that background. The US label’s own judgement is that the tablet’s common reactions were similar to the injection’s. ^[1]

A second tablet trial adds a further check. OASIS 1 tested 50 mg, which is not the approved US Wegovy® tablet strength, and its registry record lists diarrhea in 89 of 334 people on semaglutide (26.6%) and 56 of 333 on placebo (16.8%) over 75 weeks. ^[4] Again the placebo group moved with the active group. The safest reading is that diarrhea roughly doubled against placebo in both tablet trials, rather than that one form or dose is gentler.

Character, timing and the people studied

The EU description of OASIS 4 says nausea, vomiting, indigestion, diarrhea and stomach pain were mostly mild to moderate and of short duration, and that digestive events came mainly during dose escalation; the EU leaflet adds that such effects usually go away over time. ^[2] The label’s escalation runs through 1.5 mg, 4 mg and 9 mg in 30-day steps to 25 mg from day 91, and a prescriber may delay a step that is not tolerated. ^[1] No source gives tablet diarrhea step by step.

Who was studied matters when you apply these numbers to yourself. The trial excluded type 2 diabetes, and only 16 people on the tablet (8%) were aged 65 to 74 and 5 (2%) were 75 or older. ^[1] The EU text lists inflammatory bowel disease among conditions with limited experience and asks for caution, and the EU leaflet says to consult a doctor first if you have an inflammatory disease of the gut. ^[2] People with moderately reduced kidney function may have more digestive effects. ^[2]

In the registry’s full list of serious adverse events, none was a diarrhea or dehydration event in either group. ^[3] Digestive reactions as a group led 3.4% on the tablet and 2% on placebo to stop for good. ^[1]

Medicine or stomach bug?

There is no test in the label that tells the two apart, and they can overlap: gastroenteritis appears in the injection Table 3 (6% against 4% on placebo), and “stomach flu” is on the Medication Guide’s list of common side effects. ^[1] In OASIS 4 gastroenteritis was not among the events listed, which means it stayed below 5% in both groups. ^[3] In the 50 mg OASIS 1 trial it was listed at 5.4% against 3.0%. ^[4]

MedlinePlus describes viral gastroenteritis as an infection that often hits several people who shared the same food or water, with symptoms starting 4 to 48 hours after exposure and sometimes fever, chills, sweating or aching muscles; most people are better within a few days without treatment. ^[7] The NIDDK notes that diarrhea caused by some infections can also bring bloody stools, fever and chills, or vomiting. ^[5] Diarrhea that starts around a new tablet strength, without fever and without anyone else ill, fits the timing the Wegovy® documents describe, but only your clinician can sort out an individual case.

Other causes of loose stools

• Food poisoning and travellers’ diarrhea from contaminated food or water. ^[5]
• Other medicines, such as antibiotics and antacids that contain magnesium. ^[5][8]
• Sugar alcohols such as sorbitol, mannitol and xylitol, found in many sugar-free sweets and gums, and intolerance to lactose, fructose or sucrose. ^[5]
• Long-term conditions including coeliac disease, Crohn’s disease, ulcerative colitis and irritable bowel syndrome. ^[5][8]
• Infection with C. difficile, usually after antibiotics. ^[8]

Fluids first

The Wegovy® warning that matters most here is about water. The label links dehydration from diarrhea, nausea or vomiting to reports of sudden kidney injury after approval, and the Medication Guide says drinking fluids helps reduce the chance of dehydration. ^[1] The EU leaflet makes the same point and stresses it for people with kidney problems. ^[2] MedlinePlus lists thirst, a dry mouth, little or dark urine, headache and cramps as early signs, and notes that older adults and people with diabetes are at higher risk. ^[9]

For acute diarrhea, the NIDDK describes replacing fluids and electrolytes with water, broths, sports drinks or oral rehydration solutions, but asks older adults and people with diabetes, kidney disease or a weak immune system to check with their doctor before using rehydration solutions. ^[6] The NIDDK also says people over 65 are more likely to have health problems from diarrhea and should keep in touch with their doctor. ^[5]

Over-the-counter remedies and the morning window

The Wegovy® label does not discuss anti-diarrhea medicines. The NIDDK says acute diarrhea can usually be treated with over-the-counter products such as loperamide or bismuth subsalicylate, that these are generally not advised with bloody stools or fever, and that you should see a doctor if diarrhea worsens or lasts more than 2 days while using them. ^[6] MedlinePlus says the same about fever and blood. ^[8]

Two tablet rules apply to anything you swallow. Other medicines by mouth come at least 30 minutes after the Wegovy® tablet, and the label asks you to tell your provider about every prescription and non-prescription product you use, because semaglutide slows stomach emptying and can affect how some medicines work. ^[1] A pharmacist can check the timing and the combination for you.

Wegovy® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help